BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Balance Sheet of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 52.99 | 52.95 | 52.93 | 52.90 | 52.87 | |
| Total Share Capital | 52.99 | 52.95 | 52.93 | 52.90 | 52.87 | |
| Reserves and Surplus | 484.11 | 460.86 | 463.60 | 464.37 | 389.66 | |
| Total Reserves and Surplus | 484.11 | 460.86 | 463.60 | 464.37 | 389.66 | |
| Total Shareholders Funds | 537.10 | 513.81 | 521.04 | 520.70 | 445.46 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 10.91 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 21.70 | 16.72 | 14.46 | 16.01 | 6.20 | |
| Long Term Provisions | 6.59 | 2.87 | 3.17 | 0.17 | 13.44 | |
| Total Non-Current Liabilities | 28.29 | 30.50 | 17.63 | 16.18 | 19.64 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 8.86 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 69.60 | 35.95 | 22.14 | 13.41 | 21.02 | |
| Other Current Liabilities | 40.38 | 28.40 | 47.09 | 40.24 | 38.32 | |
| Short Term Provisions | 0.98 | 2.75 | 3.97 | 6.64 | 3.35 | |
| Total Current Liabilities | 110.96 | 75.96 | 73.20 | 60.29 | 62.69 | |
| Total Capital And Liabilities | 676.35 | 620.27 | 611.87 | 597.17 | 527.79 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 147.87 | 158.04 | 155.43 | 148.22 | 117.94 | |
| Intangible Assets | 8.72 | 0.25 | 0.20 | 0.09 | 0.09 | |
| Capital Work-In-Progress | 14.17 | 0.76 | 0.82 | 2.15 | 8.28 | |
| Other Assets | 0.96 | 1.00 | 1.04 | 1.08 | 1.12 | |
| Fixed Assets | 171.72 | 160.05 | 157.49 | 151.54 | 127.43 | |
| Non-Current Investments | 179.83 | 176.20 | 172.75 | 170.34 | 170.34 | |
| Deferred Tax Assets [Net] | 17.08 | 24.17 | 21.30 | 15.75 | 14.86 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 8.86 | |
| Other Non-Current Assets | 9.16 | 14.20 | 24.96 | 28.52 | 23.80 | |
| Total Non-Current Assets | 377.79 | 374.62 | 376.50 | 366.15 | 345.29 | |
| CURRENT ASSETS | ||||||
| Current Investments | 103.97 | 115.26 | 101.19 | 89.05 | 103.47 | |
| Inventories | 45.70 | 45.69 | 27.05 | 24.22 | 22.16 | |
| Trade Receivables | 68.94 | 40.20 | 83.31 | 92.78 | 44.29 | |
| Cash And Cash Equivalents | 51.98 | 34.10 | 16.39 | 12.00 | 7.67 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.06 | 0.72 | |
| OtherCurrentAssets | 27.97 | 10.40 | 7.43 | 12.91 | 4.19 | |
| Total Current Assets | 298.56 | 245.65 | 235.37 | 231.02 | 182.50 | |
| Total Assets | 676.35 | 620.27 | 611.87 | 597.17 | 527.79 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 216.39 | 299.65 | 403.69 | 0.00 | 129.05 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 31.67 | 5.11 | 3.57 | 5.91 | 3.34 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | 1.62 | 3.78 | 0.68 | 5.17 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 36.74 | 36.74 | 36.74 | 36.74 | 36.74 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | 150.34 | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 103.97 | 115.26 | 101.19 | 89.05 | 103.47 | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss